← Leaderboards
Ethel Joso Ngen
Johns Hopkins University
$3,216,249
Attributed
$3,216,249
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $584K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,216,249 · 2
By mechanism
R01$2,750,972 · 1
R21$465,277 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jeff W Bulte$21,671,493
- Charles George Eberhart$6,496,191
- Maria Roselle Abraham$2,418,862
- Cynthia Wolberger$11,583,176
- Laura Ensign$10,004,174
Others in their field
Other Emerging Leaders on “Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,487,925
- Lynn Briscoe · Leidos Biomedical Research, Inc.$121,890,535
- Yunda Huang · Fred Hutchinson Cancer Center$58,111,165
- Leonard Freedmand · Leidos Biomedical Research, Inc.$57,401,321
- John Damon Chodera · Sloan-Kettering Inst Can Research$53,758,943
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$33,980,897
Research focus
ScreeningPharmaceutical PreparationsNanocarrierResponseTheranosticsPositron-Emission TomographyIn VivoMolecularNon-Invasive ImagingProceduresHistologySignal TransductionBioluminescence ImagingAdvanced DevelopmentBiosensorImmunohistochemistryMagnetic ResonanceMagnetic Resonance ImagingDrug Delivery SystemsImageBiomaterial CompatibilityFluorescence ImagingBiodistributionDrug Release Kinetics
Grant awards (7)
Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors$554,154
R01 · FY2025 · CA · contact PI
Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors$561,666
R01 · FY2024 · CA · contact PI
Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors$571,624
R01 · FY2023 · CA · contact PI
Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors$584,003
R01 · FY2022 · CA · contact PI
Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors$479,525
R01 · FY2021 · CA · contact PI
MRI biosensors and complementary drug nanocarriers for effective image-guided drug delivery and early tumor response assessment of pediatric medulloblastomas$204,194
R21 · FY2020 · HD · contact PI
MRI biosensors and complementary drug nanocarriers for effective image-guided drug delivery and early tumor response assessment of pediatric medulloblastomas$261,083
R21 · FY2019 · HD · contact PI